Physician

George C Cheng, M.D.

According to 2025 Medicare claims, George Cheng, M.D. (NPI: 1750437745) practices radiation oncology in the Santa Maria-Santa Barbara, CA market, with the plurality of this provider's patient population coming from Santa Barbara, CA. This provider's primary affiliated billing organization is SANSUM CLINIC (NPI: 1932121514; TIN: 956419205) and primary practice location at 93105-4230. Cheng is affiliated with the Aledade A3299 CA MSSP Enhanced (ACO ID: A3299), participating under the MSSP model.

Cheng's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 433 traditional Medicare patients, billed 5,976 HCPCS/CPT codes, and received $1,189,729 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 89 prescription claims across 45 beneficiaries totaling $1,098 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). DME data shows 15 claims. Open Payments data shows 2 records totaling $166. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $586,215 to $1,189,729. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $12,360 to $1,098. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	240	3,169	$586,215
2016	316	3,982	$751,823
2017	323	3,984	$792,904
2018	294	3,557	$743,353
2019	379	5,378	$1,165,511
2020	369	4,560	$958,305
2021	394	4,948	$1,102,197
2022	429	4,496	$941,889
2023	475	5,714	$1,189,340
2024	433	5,976	$1,189,729

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	53	$12,360
2016	39	69	$1,426
2017	38	88	$3,643
2018	40	68	$1,332
2019	45	115	$2,311
2020	46	109	$2,139
2021	39	78	$2,130
2022	31	73	$1,800
2023	49	89	$4,564
2024	45	89	$1,098

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	15	$2,833

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	161	1,198	$325
77427	Radiation treatment management, 5 treatment sessions	122	376	$156
77014	Ct guidance for insertion of radiation therapy fields	196	1,345	$100
77336	Continuing radiation therapy consultation per week	237	362	$80
77300	Calculation of radiation therapy dose	128	412	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	14	975	$294

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4150	Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	15	$2,833

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$166	Galvanize Therapeutics, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for George C. Cheng, M.D.?

Tedicare shows public-source Medicare data for George C. Cheng, M.D. (NPI 1750437745), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George C. Cheng, M.D. have ACO affiliation data?

George C. Cheng, M.D. is shown with ACO affiliation data for Aledade A3299 CA MSSP Enhanced (MSSP, ACO ID A3299).

What billing organization is linked to George C. Cheng, M.D.?

George C. Cheng, M.D. is linked to SANSUM CLINIC (billing NPI 1932121514) in the available physician profile data.

Does George C. Cheng, M.D. have Open Payments data?

George C. Cheng, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.